SHANNON JAMES: Open Payments
NPI 1053898908 · GLENS FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,746 in 70 payments from 13 companies in 2025. Trend: 2023 $2,107 · 2024 $1,775 · 2025 $1,746
Food & beverage: $1,740Education: $5
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 6 | $241 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $214 |
| Axsome Therapeutics, Inc. | 8 | $205 |
| Otsuka America Pharmaceutical, Inc. | 6 | $204 |
| E.R. Squibb & Sons, L.L.C. | 5 | $201 |
| Vanda Pharmaceuticals Inc. | 13 | $183 |
| ABBVIE INC. | 3 | $149 |
| Alkermes, Inc. | 6 | $115 |
| Teva Pharmaceuticals USA, Inc. | 4 | $92 |
| Neurocrine BioSciences, Inc. | 4 | $86 |
Products named: SPRAVATO, CAPLYTA, Auvelity, COBENFY, FANAPT, VRAYLAR, REXULTI, ARISTADA.
Industry payments across NY — which companies pay providers there.
